STOCK TITAN

My Size Financials

MYSZ
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows My Size (MYSZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 37 / 100
Financial Profile 37/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
0

My Size has an operating margin of -47.8%, meaning the company retains $-48 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -96.4% the prior year.

Growth
63

My Size's revenue surged 18.0% year-over-year to $8.3M, reflecting rapid business expansion. This strong growth earns a score of 63/100.

Leverage
100

My Size carries a low D/E ratio of 0.02, meaning only $0.02 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
58

My Size's current ratio of 3.03 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
0

While My Size generated -$3.1M in operating cash flow, capex of $7K consumed most of it, leaving -$3.1M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns
0

My Size generates a -57.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -134.7% the prior year.

Piotroski F-Score Neutral
6/9

My Size passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.77x

For every $1 of reported earnings, My Size generates $0.77 in operating cash flow (-$3.1M OCF vs -$4.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$8.3M
YoY+18.0%
5Y CAGR+165.2%

My Size generated $8.3M in revenue in fiscal year 2024. This represents an increase of 18.0% from the prior year.

EBITDA
-$3.6M
YoY+43.4%

My Size's EBITDA was -$3.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 43.4% from the prior year.

Net Income
-$4.0M
YoY+37.4%

My Size reported -$4.0M in net income in fiscal year 2024. This represents an increase of 37.4% from the prior year.

EPS (Diluted)
$-4.39

My Size earned $-4.39 per diluted share (EPS) in fiscal year 2024. This represents an increase of 78.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$3.1M
YoY+49.3%

My Size generated -$3.1M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 49.3% from the prior year.

Cash & Debt
$4.9M
YoY+123.1%
5Y CAGR+32.3%
10Y CAGR+22.4%

My Size held $4.9M in cash against $146K in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
2M

My Size had 2M shares outstanding in fiscal year 2024. This represents an increase of 350.6% from the prior year.

Margins & Returns

Gross Margin
40.2%
YoY+1.2pp
5Y CAGR-26.4pp

My Size's gross margin was 40.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 1.2 percentage points from the prior year.

Operating Margin
-47.8%
YoY+48.6pp
5Y CAGR+9460.2pp

My Size's operating margin was -47.8% in fiscal year 2024, reflecting core business profitability. This is up 48.6 percentage points from the prior year.

Net Margin
-48.4%
YoY+42.8pp
5Y CAGR+8677.0pp

My Size's net profit margin was -48.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 42.8 percentage points from the prior year.

Return on Equity
-57.8%
YoY+76.9pp
5Y CAGR+465.2pp
10Y CAGR+40.1pp

My Size's ROE was -57.8% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 76.9 percentage points from the prior year.

Capital Allocation

R&D Spending
$429K
YoY-56.0%
5Y CAGR-22.3%
10Y CAGR+18.6%

My Size invested $429K in research and development in fiscal year 2024. This represents a decrease of 56.0% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$7K
YoY+0.0%
5Y CAGR-41.6%

My Size invested $7K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 0.0% from the prior year.

MYSZ Income Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Revenue $2.6M+28.2% $2.0M+35.6% $1.5M+1.6% $1.5M-20.9% $1.8M-7.1% $2.0M-33.7% $3.0M+5.4% $2.8M
Cost of Revenue $1.6M+77.2% $882K-16.7% $1.1M-4.0% $1.1M+5.2% $1.0M+5.3% $995K-44.4% $1.8M+14.1% $1.6M
Gross Profit $1.0M-10.2% $1.1M+167.6% $420K+19.3% $352K-55.5% $791K-19.6% $984K-17.7% $1.2M-5.3% $1.3M
R&D Expenses $131K-7.7% $142K+73.2% $82K+6.5% $77K-13.5% $89K-32.1% $131K-0.8% $132K-19.0% $163K
SG&A Expenses $1.0M+10.6% $904K+8.8% $831K+4.4% $796K+24.4% $640K-28.8% $899K-13.0% $1.0M+35.7% $761K
Operating Income -$1.4M-131.4% -$586K+44.7% -$1.1M-53.6% -$690K+47.2% -$1.3M-48.9% -$877K+18.1% -$1.1M+32.6% -$1.6M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A -$133K
Net Income -$1.3M-196.7% -$450K+57.5% -$1.1M-48.3% -$715K+45.0% -$1.3M-34.9% -$964K+5.1% -$1.0M+22.0% -$1.3M
EPS (Diluted) $-0.40-166.7% $-0.15+70.6% $-0.51 N/A $-1.25+2.3% $-1.28 $-1.88 N/A

MYSZ Balance Sheet

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Total Assets $11.7M+18.2% $9.9M+12.7% $8.8M-13.0% $10.1M+43.0% $7.0M-12.2% $8.0M+20.1% $6.7M-25.8% $9.0M
Current Assets $9.1M+8.0% $8.4M+7.8% $7.8M-14.0% $9.1M+52.5% $5.9M-4.1% $6.2M+30.5% $4.8M-28.3% $6.6M
Cash & Equivalents $4.5M+4.9% $4.3M+15.9% $3.7M-24.3% $4.9M+105.8% $2.4M-25.9% $3.2M+181.8% $1.1M-48.1% $2.2M
Inventory $3.3M+15.3% $2.9M+15.9% $2.5M-10.4% $2.8M+24.9% $2.2M+24.8% $1.8M-16.1% $2.1M-25.8% $2.9M
Accounts Receivable $506K+27.1% $398K-25.5% $534K+92.1% $278K-15.0% $327K-0.6% $329K-19.0% $406K-34.0% $615K
Goodwill $686K+383.1% $142K+6.8% $133K0.0% $133K+1.5% $131K-1.5% $133K-82.1% $742K-2.1% $758K
Total Liabilities $4.4M+78.0% $2.4M-10.1% $2.7M-13.6% $3.1M+22.4% $2.6M+11.1% $2.3M-20.6% $2.9M-31.5% $4.3M
Current Liabilities $3.3M+54.2% $2.2M-16.5% $2.6M-13.7% $3.0M+25.6% $2.4M+13.1% $2.1M-21.9% $2.7M-30.4% $3.9M
Long-Term Debt $832K+804.3% $92K-30.8% $133K-8.9% $146K-17.5% $177K-8.3% $193K-11.5% $218K-12.4% $249K
Total Equity $7.3M-1.6% $7.4M+23.0% $6.0M-12.7% $6.9M+55.0% $4.5M-21.7% $5.7M+51.7% $3.8M-20.7% $4.7M
Retained Earnings -$66.7M-2.0% -$65.4M-0.7% -$64.9M-1.7% -$63.9M-1.1% -$63.2M-2.1% -$61.9M-1.6% -$60.9M-1.7% -$59.9M

MYSZ Cash Flow Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Operating Cash Flow -$500K+51.8% -$1.0M+18.1% -$1.3M-122.8% -$569K-27.3% -$447K+32.2% -$659K+53.5% -$1.4M-18.5% -$1.2M
Capital Expenditures $0 N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow -$500K N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$142K N/A N/A -$7K $0 $0-100.0% $60K N/A
Financing Cash Flow $820K-54.3% $1.8M+1789.5% $95K-96.8% $3.0M+986.0% -$335K-113.1% $2.6M+527.5% $407K+524.0% -$96K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

MYSZ Financial Ratios

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Gross Margin 39.2%-16.8pp 56.0%+27.6pp 28.4%+4.2pp 24.2%-18.8pp 43.0%-6.7pp 49.7%+9.6pp 40.1%-4.5pp 44.6%
Operating Margin -52.7%-23.5pp -29.2%+42.5pp -71.7%-24.3pp -47.4%+23.6pp -71.0%-26.7pp -44.3%-8.4pp -35.9%+20.3pp -56.2%
Net Margin -51.9%-29.5pp -22.4%+49.2pp -71.7%-22.5pp -49.1%+21.5pp -70.7%-22.0pp -48.7%-14.7pp -34.1%+12.0pp -46.0%
Return on Equity -18.3%-12.2pp -6.1%+11.5pp -17.6%-7.2pp -10.3%+18.8pp -29.2%-12.2pp -16.9%+10.1pp -27.1%+0.5pp -27.5%
Return on Assets -11.5%-6.9pp -4.6%+7.5pp -12.1%-5.0pp -7.1%+11.4pp -18.5%-6.5pp -12.0%+3.2pp -15.2%-0.7pp -14.5%
Current Ratio 2.73-1.2 3.89+0.9 3.02-0.0 3.03+0.5 2.49-0.4 2.94+1.2 1.76+0.1 1.71
Debt-to-Equity 0.11+0.1 0.010.0 0.020.0 0.02-0.0 0.040.0 0.03-0.0 0.060.0 0.05
FCF Margin -19.4% N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

My Size (MYSZ) reported $8.3M in total revenue for fiscal year 2024. This represents a 18.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

My Size (MYSZ) revenue grew by 18% year-over-year, from $7.0M to $8.3M in fiscal year 2024.

No, My Size (MYSZ) reported a net income of -$4.0M in fiscal year 2024, with a net profit margin of -48.4%.

My Size (MYSZ) reported diluted earnings per share of $-4.39 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

My Size (MYSZ) had EBITDA of -$3.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, My Size (MYSZ) had $4.9M in cash and equivalents against $146K in long-term debt.

My Size (MYSZ) had a gross margin of 40.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

My Size (MYSZ) had an operating margin of -47.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

My Size (MYSZ) had a net profit margin of -48.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

My Size (MYSZ) has a return on equity of -57.8% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

My Size (MYSZ) generated -$3.1M in free cash flow during fiscal year 2024. This represents a 49.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

My Size (MYSZ) generated -$3.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

My Size (MYSZ) had $10.1M in total assets as of fiscal year 2024, including both current and long-term assets.

My Size (MYSZ) invested $7K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

My Size (MYSZ) invested $429K in research and development during fiscal year 2024.

My Size (MYSZ) had 2M shares outstanding as of fiscal year 2024.

My Size (MYSZ) had a current ratio of 3.03 as of fiscal year 2024, which is generally considered healthy.

My Size (MYSZ) had a debt-to-equity ratio of 0.02 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

My Size (MYSZ) had a return on assets of -39.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2024 data, My Size (MYSZ) had $4.9M in cash against an annual operating cash burn of $3.1M. This gives an estimated cash runway of approximately 19 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

My Size (MYSZ) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

My Size (MYSZ) has an earnings quality ratio of 0.77x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

My Size (MYSZ) scores 37 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top